Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission

Blood Adv. 2024 May 28;8(10):2405-2409. doi: 10.1182/bloodadvances.2023012139.

Irene Urbino^{1

2}, Etienne Lengliné³, Florence Rabian¹, Marco Cerrano², Rathana Kim^{4

5}, Florian Chevillon¹, Dario Ferrero⁶, Marie Sébert⁴, Nathalie Dhédin¹, Raphaël Itzykson³, Lionel Adès⁷, Emmanuel Raffoux³, Hervé Dombret^{3

8}, Ernesta Audisio², Emmanuelle Clappier^{4

5}, Nicolas Boissel^{1

8}

¹ Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
² Division of Hematology, Department of Oncology, Città della Salute e della Scienza, Turin, Italy.
³ Adult Hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Université Paris Cité, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, Centre National de la Recherche Scientifique, Paris, France.
⁵ Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁶ Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
⁷ Senior Hematology Unit, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁸ URP-3518, Institut de Recherche Saint-Louis, Université de Paris Cité, Paris, France.

No abstract available

MeSH terms